AI Safe Value Fund vs Uranium Squeeze Fund
A comparison of two published records. This is a side-by-side table of the same fields for each Portfolio. It is not a ranking, a score, or a recommendation.
Open in the interactive pickerPublished directory
| Field | AI Safe Value Fund Current as of 2026-10-02 HTMLMarkdownJSON | Uranium Squeeze Fund Current as of 2026-10-05 HTMLMarkdownJSON |
|---|---|---|
| Cite | HTMLMarkdownJSON | HTMLMarkdownJSON |
| Published Pilot | Derek Quick | Derek Quick |
| Sleeves | AI | AI |
| Slug | ai-safe-value-fund | uranium-squeeze-fund |
| Portfolio key | 1023712 | 1198241 |
| Status | ACTIVE | ACTIVE |
| Provenance | Autopilot client composite since launch | Autopilot client composite since launch |
| Inception | 2026-04-24 | 2026-06-25 |
| As of | 2026-10-02 | 2026-10-05 |
| Window | 2026-04-24 → 2026-10-02 | 2026-06-25 → 2026-10-05 |
| Days live | 161 | 102 |
| Maturity | NASCENT | NASCENT |
| Risk band | MEDIUM | HIGH |
| Objective | The AI Safe Value opportunity is positioned to outperform the market in a downturn, the focused recovery is across the best healthcare, and GLP1 stocks, where sentiment has pushed high quality companies to multi year or decade lows. These businesses still generate strong revenue and free cash flow, yet are priced as if their fundamentals are permanently impaired, creating a setup similar to past cycles that led to significant re-rating. This is an actively managed portfolio that I spend hours daily growing and protecting in a bear or bull market. I focus on identifying mispriced assets early with massive upside, before sentiment shifts and capital rotates back in. AI is creating massive margin recovery in overlooked defensive stocks, with healthcare as a core theme trading near dot com era relative lows despite free cash flow and AI driven efficiencies. Full thesis documentary. https://www.youtube.com/watch?v=LXqCpqUHDY0 | There is a 2.3 billion pound uranium cumulative deficit coming by 2040 as per Goldman Sachs while there is record demand for base load energy by 2030 from not just AI but many competing sectors, this makes they tiny Uranium sector a potential for a major squeeze where we see a 1970's Uranium price run to all time highs. Simple supply and demand. This is an actively managed portfolio that I spend hours daily growing and protecting in a bear or bull market. I have been covering Uranium stocks for the past seven years, making hundreds of videos and multiple documentaries on the sector spending tens of thousands of hours on the opaque uranium stock sector. I also originally bought almost every uranium stock at the time at their march 2020 lows and have been covering them ever since. https://www.youtube.com/watch?v=ffAhpB8aeKE&t=2734s |
| Past week net | -2.0% | 0.2% |
| Past week gross | -2.0% | 0.2% |
| 1Y net | n/a | n/a |
| 1Y gross | n/a | n/a |
| Since inception net | -1.1% | -27.1% |
| Since inception gross | -1.1% | -27.1% |
| All-time gross | -1.1% | -27.1% |
| CAGR net | n/a | n/a |
| CAGR gross | n/a | n/a |
| Sharpe | n/a | n/a |
| Sortino | n/a | n/a |
| Max DD | -22.2% | -28.9% |
| AUM | $37.0k | $704 |
| Current subscription | Derek Quick's Team - Full Access: Quarterly $80.00; Yearly $275.00 | Derek Quick's Team - Full Access: Quarterly $80.00; Yearly $275.00 |
About AutopilotBrowse thematic sleeves
Performance disclaimer
The performance data presented reflects the aggregated results of actual client portfolios managed by the Registered Investment Adviser (RIA), based on the trading activity in the securities contained in the relevant portfolio over the specified period. If fewer than 10 clients are invested in the portfolio, the data represents the aggregate performance of all clients following this strategy. Actual investor outcomes can vary due to factors like brokerage support for fractional shares, account size, trade timing, fees, and taxes, and past performance should not be interpreted as a guarantee of future results or typical of all portfolios. Performance figures are shown before Pilot subscription amounts. Autopilot does not charge an advisory fee.
"Autopilot" refers to Autopilot Holdings Corp and Autopilot Advisers, LLC, an SEC-registered investment adviser. Investing carries risk-including possible loss of principal-and past performance is not indicative of future results. Figures current as of 10/05/26. Performance shown reflects the period from 9/28/26 - 10/05/26. AI Safe Value Fund: past week -2.0%; since inception (4/24/26) -1.1%. No Autopilot advisory fee is deducted; representative client-account sample (all accounts if fewer than 10 clients). Uranium Squeeze Fund: past week +0.2%; since inception (6/25/26) -27.1%. No Autopilot advisory fee is deducted; representative client-account sample (all accounts if fewer than 10 clients). Not a recommendation. View important info at joinautopilot.com/disclaimer.
For agents
Canonical HTML: /compare/ai-safe-value-fund-vs-uranium-squeeze-fund. Structured rows: /api/portfolios/compare?ids=ai-safe-value-fund,uranium-squeeze-fund. This is an all-or-nothing pair, not a ranking.
Notes
This is a side-by-side table of the same fields for each Portfolio. It is not a ranking, a score, or a recommendation.
Autopilot does not charge an advisory fee and does not charge an AUM fee. The price to follow a Pilot is that Pilot's subscription. If you subscribe to more than one Pilot, those subscription amounts add. Pilot subscriptions are not deducted from the published return figures.
While individual Portfolios may each be suitable for your risk profile, combining multiple Portfolios may create concentration risks or unsuitable aggregate exposure. Autopilot does not assess aggregate suitability across multiple Portfolios.